Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
Amgen
AMGN
|
$1.68B |
| 2 |
Ingersoll Rand
IR
|
$1.32B |
| 3 |
Alphabet (Google) Class C
GOOG
|
$1.14B |
| 4 |
Charter Communications
CHTR
|
$1.07B |
| 5 |
GE Aerospace
GE
|
$932M |
Top Sells
| 1 |
Broadcom
AVGO
|
$3.09B |
| 2 |
Meta Platforms (Facebook)
META
|
$2.55B |
| 3 |
Zoetis
ZTS
|
$2.47B |
| 4 |
Johnson & Johnson
JNJ
|
$1.87B |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$1.34B |
Sector Composition
| 1 | Technology | 24.7% |
| 2 | Financials | 14.61% |
| 3 | Industrials | 14.19% |
| 4 | Healthcare | 12.1% |
| 5 | Communication Services | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
SPX Corp
SPXC
$9.25B
| $21.8M | ﹤0.01% | +177,203 | New | +$21.8M |
|
377
Pliant Therapeutics
PLRX
$101M
| $20.5M | ﹤0.01% | 1,377,327 +464,860 | +51% | +$6.93M |
|
378
Capital Group Short Duration Municipal Income ETF
CGSM
$800M
| $20.5M | ﹤0.01% | 798,000 +133,000 | +20% | +$3.42M |
|
379
iShares MSCI ACWI ETF
ACWI
$22B
| $20.3M | ﹤0.01% | 184,286 -306,081 | -62% | -$33.7M |
|
380
Atkore
ATKR
$1.96B
| $20M | ﹤0.01% | 105,245 | – | – |
|
381
Live Oak Bancshares
LOB
$1.77B
| $18.6M | ﹤0.01% | +448,766 | New | +$18.6M |
|
382
Goosehead Insurance
GSHD
$2.15B
| $17.6M | ﹤0.01% | 264,132 +180 | +0.1% | +$12K |
|
383
Vesta Real Estate
VTMX
$2.32B
| $17.3M | ﹤0.01% | 441,920 +6,252 | +1% | +$245K |
|
|
384
Zoetis
ZTS
$69.3B
| $16.8M | ﹤0.01% | 99,440 -14,577,136 | -99% | -$2.47B |
|
385
Vicor
VICR
$2.3B
| $14.5M | ﹤0.01% | 378,100 | – | – |
|
386
Arrowhead Research
ARWR
$3.05B
| $13.7M | ﹤0.01% | 479,106 -798,454 | -62% | -$22.8M |
|
387
Capital Group Core Bond ETF
CGCB
$2.89B
| $13.7M | ﹤0.01% | 527,000 -483,000 | -48% | -$12.6M |
|
388
KB Financial Group
KB
$28.6B
| $13.3M | ﹤0.01% | 254,968 +19,260 | +8% | +$1M |
|
389
Gogo Inc
GOGO
$1.47B
| $13.1M | ﹤0.01% | 1,490,155 | – | – |
|
390
Ventyx Biosciences
VTYX
$171M
| $12.9M | ﹤0.01% | 2,354,149 | – | – |
|
391
Zai Lab
ZLAB
$3.68B
| $12.9M | ﹤0.01% | 806,453 | – | – |
|
392
XPEL
XPEL
$1.03B
| $12.9M | ﹤0.01% | 238,511 | – | – |
|
393
SPDR S&P 500 ETF Trust
SPY
$658B
| $12.5M | ﹤0.01% | 23,906 -19,187 | -45% | -$10M |
|
394
Li Auto
LI
$23.7B
| $11.8M | ﹤0.01% | 389,400 +4,422 | +1% | +$134K |
|
395
Pacific Biosciences
PACB
$393M
| $11.7M | ﹤0.01% | 3,113,749 | – | – |
|
396
Dow Inc
DOW
$17.5B
| $11.4M | ﹤0.01% | 197,546 +12,788 | +7% | +$741K |
|
397
Entegris
ENTG
$12.7B
| $11.1M | ﹤0.01% | 79,014 | – | – |
|
|
CERE
398
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $10.7M | ﹤0.01% | 253,495 -610,291 | -71% | -$25.8M |
|
399
Lam Research
LRCX
$127B
| $10M | ﹤0.01% | 10,295 +5,544 | +117% | +$5.39M |
|
400
Teradata
TDC
$1.98B
| $9.07M | ﹤0.01% | 234,529 | – | – |
|